IPO Update: Avantor Plans $3 Billion U.S. IPO
Quick Take Avantor (AVTR) has filed to raise $3 billion from an IPO, per an amended registration statement . The company provides a wide variety of biomedical products and services to research organizations...
Bio-Rad (BIO) Q1 Earnings Beat Estimates, Margins Expand
Bio-Rad (BIO) witnesses revenue growth at the Life Sciences segment in Q1 on strength in cell biology, droplet Digital PCR and other product lines.
Edited Transcript of BIO earnings conference call or presentation 8-May-19 9:00pm GMT
Q1 2019 Bio Rad Laboratories Inc Earnings Call
Bio-Rad Laboratories Inc (BIO) Q1 2019 Earnings Call Transcript
BIO earnings call for the period ending March 31, 2019.
Bio-Rad Laboratories, Inc. (BIO) CEO Norman Schwartz on Q1 2019 Results - Earnings Call Transcript
Bio-Rad Laboratories. Inc. (BIO) Q1 2019 Earnings Conference Call May 08, 2019 05:00 PM ET Company Participants Ron Hutton - Vice President and Treasurer Ilan Daskal - EVP and CFO Norman...
Bio-Rad Laboratories (BIO) Q1 Earnings and Revenues Beat Estimates
Bio-Rad (BIO) delivered earnings and revenue surprises of 47.32% and 0.94%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Bio-Rad: 1Q Earnings Snapshot
The Hercules, California-based company said it had net income of $28.74 per share. Earnings, adjusted for one-time gains and costs, came to $1.65 per share. The maker of instruments used in biomedical...
Bio-Rad Labs beats by $0.50, beats on revenue
Bio-Rad Labs (NYSE: BIO ): Q1 Non-GAAP EPS of $1.65 beats by $0.50 ; GAAP EPS of $28.74. More news on: Bio-Rad Laboratories, Inc., Earnings news and commentary, Tech stocks news, Read more …
Bio-Rad Reports First Quarter 2019 Financial Results
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced financial results for the first quarter ended March 31, 2019....
Bio-Rad Labs Q1 Earnings Preview
Bio-Rad Labs (NYSE: BIO ) is scheduled to announce Q1 earnings results on Wednesday, May 8th, after market close. The consensus EPS Estimate is $1.15 (-1.7% Y/Y) and the consensus Revenue Estimate...
In 2017, Biome Grow arrived in Canada’s cannabis market with a different approach than its competitors. Biome is focused on the local consumer - what they want in a product, and in a buying experience. Our focus is on the regional cannabis growing and business growth with an emphasis in Atlantic Canada and Ontario.
We are built to become the next Canadian cannabis conglomerate. With our five brands, Biome is steered by recognized experts in the cannabis space - in finance, growing technologies, regulatory affairs, business building and marketing. Biome is built for growth and built to last in an exciting but volatile space that will see transformative changes in the months and years to come.
In May 2018, Biome and our first subsidiary and brand, Highland Grow announced the expansion of its Nova Scotia production facility. The expanded facility will include extensive research and development facilities that will be used by Biome and its external partners, including St. Francis Xavier University.
We are expanding our facility to better incorporate R&D capabilities, with an eye to establishing a cannabis centre of excellence in Antigonish, Nova Scotia.
Highland Grow’s mandate is focused on building a local cannabis business that is designed to primarily cater to Nova Scotians. Highland Grow has been founded by Nova Scotians and is managed by Nova Scotians.
In June 2018, we acquired Weed VR, a new virtual reality technology platform focused exclusively on the medical and recreational cannabis markets. Bringing Weed VR into the Biome family of brands, allows us to integrate new technology into our services and increase consumer accessibility across Canada, and international markets, through virtual, augmented, and mobile platforms.
In October 2018, Biome Grow began publicly trading in Canada and Frankfurt. Since then Biome has added our fifth subsidiary company and brand, Red Sands Craft Cannabis Co. Red Sands is third of Biome Grow’s Atlantic Canadian brands. Located in Prince Edward Island, the brand reflects PEI’s iconic red sand beaches and the craft goods and services that are produced locally. Visually, it balances the vibrant, energetic colours with the calm nature that PEI is known for, setting the stage for the tailored cannabis products that Red Sands will offer.
On October 24th,2018, Biome introduced its Ontario-based subsidiary and brand, Great Lakes Cannabis (“Great Lakes Cannabis”). Located in Norwich, Ontario, Great Lakes Cannabis will serve Biome’s national and international markets with Canadian-grown cannabis. Like its same sake the Great Lakes that lie in separate basins, but form a single, naturally interconnected body of fresh water, Great Lakes Cannabis is a separate production facility that is interconnected with Biome’s other regional brands, creating a unified Canadian-cannabis biome.
In November 2018, Biome Grow announced that our second subsidiary and brand Back Home Medical Cannabis Corporation had entered into a production and supply agreement with the Province of Newfoundland and Labrador.The announcement is the third largest deal in the Canadian cannabis market.
This new $52 million production facility will be constructed in two phases, an initial 18,000 square foot facility, followed by the expansion of 150,000 square feet. This expansion brings the Company’s total licensed footprint to 168,000 square feet, making Biome Grow’s brand Back Home the largest cannabis production facility in Newfoundland.
In this agreement, Biome has also been approved for five retail licenses. The first of the stores will located in Western Newfoundland with close proximity to our production facility.
From our strategic investments into regional footprints which position us for global expansion, to our partnerships in research and development, we are changing the way you see cannabis companies.